RIPK1 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma, RIPK1 downregulation increased the risk of metastasis through inhibition of NF-κB-pathway-dependent TLR3 receptor and by promoting apoptosis over necrosis [51].